Trial
NCT04830878
Methotrexate For The Prevention and Treatment of Proliferative Vitreoretinopathy in Pediatric Patients
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Stanford University
Collaborators
—
Condition
Proliferative Vitreoretinopathy
Intervention
Methotrexate
Why stopped
Lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-04-20